Farjam M - Search Results

1

The PERSIAN Cohort: Providing the Evidence Needed for Healthcare Reform.

Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E, Joukar F, Hamzeh B, Farjam M, Zare Sakhvidi MJ, Miri-Monjar M, Moosazadeh M, Hakimi H, Rahimi Kazerooni S, Cheraghian B, Ahmadi A, Nejatizadeh A, Mohebbi I, Pourfarzi F, Roozafzai F, Motamed-Gorji N, Montazeri SA, Masoudi S, Amin-Esmaeili M, Danaie N, Mirhafez SR, Hashemi H, Poustchi H, Malekzadeh R. Eghtesad S, et al. Arch Iran Med. 2017 Nov 1;20(11):691-695. Arch Iran Med. 2017. PMID: 29480734

2

Gold nanoparticle decorated dithiocarbamate modified natural boehmite as a catalyst for the synthesis of biologically essential propargylamines.

Zarenezhad E, Taghavi R, Kamrani P, Farjam M, Rostamnia S. Zarenezhad E, et al. RSC Adv. 2022 Nov 7;12(49):31680-31687. doi: 10.1039/d2ra03725d. eCollection 2022 Nov 3. RSC Adv. 2022. PMID: 36380962 Free PMC article.

3

A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa Cohort Study.

Farjam M, Bahrami H, Bahramali E, Jamshidi J, Askari A, Zakeri H, Homayounfar R, Poustchi H, Malekzadeh R. Farjam M, et al. BMC Public Health. 2016 Oct 18;16(1):1090. doi: 10.1186/s12889-016-3760-z. BMC Public Health. 2016. PMID: 27756262 Free PMC article.

4

Socioeconomic gradient in physical activity: findings from the PERSIAN cohort study.

Kazemi Karyani A, Karmi Matin B, Soltani S, Rezaei S, Soofi M, Salimi Y, Moradinazar M, Hajizadeh M, Pasdar Y, Hamzeh B, Barzegar L, Haghdoost AA, Malekzadeh R, Poustchi H, Mohammadi Z, Faramarzi E, Safarpour AR, Pourfarzi F, Moosazadeh M, Nejatizadeh A, Farjam M, Vahabzadeh D, Ahmadi A, Ghorat F, Ahmadi J, Mansour-Ghanaei F, Mirjalili MR, Eslami S, Maharlouei N, Tabatabaei SM, Sarvandian S, Najafi F. Kazemi Karyani A, et al. BMC Public Health. 2019 Oct 21;19(1):1312. doi: 10.1186/s12889-019-7715-z. BMC Public Health. 2019. PMID: 31638932 Free PMC article.

5

Repositioning of the global epicentre of non-optimal cholesterol.

NCD Risk Factor Collaboration (NCD-RisC). NCD Risk Factor Collaboration (NCD-RisC). Nature. 2020 Jun;582(7810):73-77. doi: 10.1038/s41586-020-2338-1. Epub 2020 Jun 3. Nature. 2020. PMID: 32494083 Free PMC article.

6

Prevalence of drug use, alcohol consumption, cigarette smoking and measure of socioeconomic-related inequalities of drug use among Iranian people: findings from a national survey.

Moradinazar M, Najafi F, Jalilian F, Pasdar Y, Hamzeh B, Shakiba E, Hajizadeh M, Haghdoost AA, Malekzadeh R, Poustchi H, Nasiri M, Okati-Aliabad H, Saeedi M, Mansour-Ghanaei F, Farhang S, Safarpour AR, Maharlouei N, Farjam M, Amini S, Amini M, Mohammadi A, Mirzaei-Alavijeh M. Moradinazar M, et al. Subst Abuse Treat Prev Policy. 2020 Jun 5;15(1):39. doi: 10.1186/s13011-020-00279-1. Subst Abuse Treat Prev Policy. 2020. PMID: 32503660 Free PMC article.

7

Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants.

NCD Risk Factor Collaboration (NCD-RisC). NCD Risk Factor Collaboration (NCD-RisC). Lancet. 2020 Nov 7;396(10261):1511-1524. doi: 10.1016/S0140-6736(20)31859-6. Lancet. 2020. PMID: 33160572 Free PMC article.

8

Investigating the prevalence of hypertension and its associated risk factors in a population-based study: Fasa PERSIAN COHORT data.

Bijani M, Parvizi S, Dehghan A, Sedigh-Rahimabadi M, Rostami-Chijan M, Kazemi M, Naghizadeh MM, Ghaemi A, Homayounfar R, Farjam M. Bijani M, et al. BMC Cardiovasc Disord. 2020 Dec 1;20(1):503. doi: 10.1186/s12872-020-01797-3. BMC Cardiovasc Disord. 2020. PMID: 33256609 Free PMC article.

9

Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight.

NCD Risk Factor Collaboration (NCD-RisC). NCD Risk Factor Collaboration (NCD-RisC). Elife. 2021 Mar 9;10:e60060. doi: 10.7554/eLife.60060. Elife. 2021. PMID: 33685583 Free PMC article.

10

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.

NCD Risk Factor Collaboration (NCD-RisC). NCD Risk Factor Collaboration (NCD-RisC). Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24. Lancet. 2021. PMID: 34450083 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters